MannKind Corp. (MNKD)
4.075
-0.08
(-1.81%)
USD |
NASDAQ |
Aug 24, 16:00
4.075
0.00 (0.00%)
After-Hours: 20:00
MannKind Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 27, 2014 | 220.65 |
| June 26, 2014 | 233.45 |
| June 25, 2014 | 233.67 |
| June 24, 2014 | 233.89 |
| June 23, 2014 | 236.76 |
| June 20, 2014 | 228.38 |
| June 19, 2014 | 232.13 |
| June 18, 2014 | 232.57 |
| June 17, 2014 | 233.89 |
| June 16, 2014 | 235.00 |
| June 13, 2014 | 232.13 |
| June 12, 2014 | 215.83 |
| June 11, 2014 | 228.38 |
| June 10, 2014 | 232.35 |
| June 09, 2014 | 236.10 |
| June 06, 2014 | 226.83 |
| June 05, 2014 | 221.54 |
| June 04, 2014 | 232.57 |
| June 03, 2014 | 209.84 |
| June 02, 2014 | 199.25 |
| May 30, 2014 | 196.38 |
| May 29, 2014 | 188.66 |
| May 28, 2014 | 180.27 |
| May 27, 2014 | 176.52 |
| May 23, 2014 | 171.45 |
| Date | Value |
|---|---|
| May 22, 2014 | 171.23 |
| May 21, 2014 | 172.22 |
| May 20, 2014 | 167.03 |
| May 19, 2014 | 163.06 |
| May 16, 2014 | 154.90 |
| May 15, 2014 | 152.91 |
| May 14, 2014 | 154.68 |
| May 13, 2014 | 145.19 |
| May 12, 2014 | 139.67 |
| May 09, 2014 | 137.25 |
| May 08, 2014 | 135.92 |
| May 07, 2014 | 136.80 |
| May 06, 2014 | 138.13 |
| May 05, 2014 | 141.44 |
| May 02, 2014 | 140.11 |
| May 01, 2014 | 142.10 |
| April 30, 2014 | 144.53 |
| April 29, 2014 | 141.44 |
| April 28, 2014 | 137.03 |
| April 25, 2014 | 137.47 |
| April 24, 2014 | 140.78 |
| April 23, 2014 | 140.34 |
| April 22, 2014 | 142.32 |
| April 21, 2014 | 139.67 |
| April 17, 2014 | 137.91 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| United Therapeutics Corp. | 3.421 |
| ACADIA Pharmaceuticals, Inc. | 3.903 |
| Gilead Sciences, Inc. | 15.40 |
| Vertex Pharmaceuticals, Inc. | 6.854 |
| Ocugen, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.200 |
| Price | 4.075 |
| Earnings Yield | -3.48% |
| Market Cap | 1.263B |
| Operating PE Ratio | 94.83 |